Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Jonathan Van Ness is seen on the Netflix show, Queer Eye. He has, for the first time, spoken publicly about using weight loss ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...